Suppr超能文献

通过放射性配体结合鉴定N1E-115神经母细胞瘤细胞膜中的5-羟色胺5-HT3识别位点。

Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.

作者信息

Hoyer D, Neijt H C

机构信息

Preclinical Research, Sandoz Ltd, Basel, Switzerland.

出版信息

Mol Pharmacol. 1988 Mar;33(3):303-9.

PMID:3352595
Abstract

[3H]ICS 205-930 recognition sites were analyzed in membranes prepared from murine neuroblastoma N1E-115 cells. [3H]ICS 205-930 bound rapidly, reversibly, and stereoselectively to a homogeneous population of high affinity recognition sites: Bmax = 40 +/- 5 fmol/mg of protein, pKD = 9.20 +/- 0.05 (n = 11). Nonlinear regression and Scatchard analysis of saturation data suggested the existence of a single class of [3H]ICS 205-930 recognition sites on N1E-115 cells. The affinity of [3H]ICS 205-930 determined in kinetic studies was in agreement with that obtained under equilibrium conditions. Competition studies carried out with a large variety of agonists and antagonists also suggested the presence of a homogeneous population of [3H]ICS 205-930 recognition sites. [3H]ICS 205-930-binding sites displayed the pharmacological profile of a 5-HT3 receptor. Potent 5-HT3 receptor antagonists showed nM affinities for [3H]ICS 205-930-binding sites with the following rank order of potency: SDZ 206-830 greater than SDZ 206-792 greater than ICS 205-930 greater than BRL 43694 greater than quipazine greater than BRL 24924 greater than MDL 72222 greater than GR 38032F. Methiothepine, mCPP, and metoclopramide showed sub-microM affinity. The rank order of potency of agonists was: 5-HT greater than phenylbiguanide = 2-methyl-5-HT much greater than 5-methoxytryptamine = 5-carboxamidotryptamine. All antagonist competition curves were steep (pseudo-Hill coefficients not lower than 1), monophasic, and best fit for a one-site model; 5-HT and 2-methyl-5-HT produced pseudo-Hill coefficients of 1.2-1.4. Drugs acting at 5-HT1, 5-HT2, alpha- and beta-adrenergic, dopaminergic, and histaminergic receptors (methysergide, ketanserin, propranolol, phentolamine, sulpiride, SCH 23390, cimetidine) were essentially inactive at 10 mumol/liter. The binding of [3H]ICS 205-930 was not affected by guanine and adenine nucleotides (GTP, GppNHp, and ATP) at 1 mmol/liter. These nucleotides did not affect the binding of agonists, suggesting that 5-HT3 recognition sites are not coupled to G-proteins. The interactions of agonists and antagonists with [3H]ICS 205-930 recognition sites were competitive in nature, as demonstrated by saturation experiments carried out with [3H]ICS 205-930 in the presence and the absence of unlabeled compounds: apparent Bmax values were not reduced, whereas apparent KD values were increased in the presence of competing ligands.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在从小鼠神经母细胞瘤N1E - 115细胞制备的膜中分析了[3H]ICS 205 - 930识别位点。[3H]ICS 205 - 930能快速、可逆且立体选择性地结合到一类均一的高亲和力识别位点上:最大结合量(Bmax)= 40±5 fmol/mg蛋白质,解离常数的负对数(pKD)= 9.20±0.05(n = 11)。对饱和数据进行非线性回归和Scatchard分析表明,N1E - 115细胞上存在一类单一的[3H]ICS 205 - 930识别位点。动力学研究中测定的[3H]ICS 205 - 930的亲和力与平衡条件下获得的结果一致。用多种激动剂和拮抗剂进行的竞争研究也表明存在一类均一的[3H]ICS 205 - 930识别位点。[3H]ICS 205 - 930结合位点表现出5 - HT3受体的药理学特征。强效5 - HT3受体拮抗剂对[3H]ICS 205 - 930结合位点显示出纳摩尔级亲和力,其效价顺序如下:SDZ 206 - 830>SDZ 206 - 792>ICS 205 - 930>BRL 43694>喹哌嗪>BRL 24924>MDL 72222>GR 38032F。甲硫噻嗪、mCPP和甲氧氯普胺显示出亚微摩尔级亲和力。激动剂的效价顺序为:5 - HT>苯甲胍 = 2 - 甲基 - 5 - HT>>5 - 甲氧基色胺 = 5 - 羧酰胺色胺。所有拮抗剂竞争曲线均陡峭(伪希尔系数不低于1)、单相,最适合单点模型;5 - HT和2 - 甲基 - 5 - HT产生的伪希尔系数为1.2 - 1.4。作用于血清素1(5 - HT1)、血清素2(5 - HT2)、α和β肾上腺素能、多巴胺能和组胺能受体的药物(麦角新碱、酮色林、普萘洛尔、酚妥拉明、舒必利、SCH 23390、西咪替丁)在10 μmol/L时基本无活性。1 mmol/L的鸟嘌呤和腺嘌呤核苷酸(GTP、GppNHp和ATP)不影响[3H]ICS 205 - 930的结合。这些核苷酸不影响激动剂的结合,表明5 - HT3识别位点不与G蛋白偶联。如在有和没有未标记化合物存在的情况下用[3H]ICS 205 - 930进行的饱和实验所示,激动剂和拮抗剂与[3H]ICS 205 - 930识别位点的相互作用本质上是竞争性的:表观最大结合量(Bmax)值未降低,而在有竞争配体存在时表观解离常数(KD)值增加。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验